Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Doxorubicin Adverse Reaction”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Not applicableStudy completedNCT02796365
What this trial is testing

Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy

Who this might be right for
Doxorubicin Induced CardiomyopathyBreast CancerGastric Cancer+1 more
Henry Ford Health System 29
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Large-scale testing (Phase 3)Study completedNCT00245050
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganEndometrial Cancer+3 more
Case Comprehensive Cancer Center 34
Not applicableLooking for participantsNCT05467111
What this trial is testing

Cardioprotective Effect of Acute Exercise in Breast Cancer Patients

Who this might be right for
Early-stage Breast Cancer
Technical University of Madrid 40
Testing effectiveness (Phase 2)Study completedNCT01095926
What this trial is testing

Pharmacokinetic Study of Doxorubicin in Children With Cancer

Who this might be right for
Wilms TumorNeuroblastomaSoft Tissue Sarcoma+1 more
University Hospital Muenster 101
Testing effectiveness (Phase 2)Looking for participantsNCT03934905
What this trial is testing

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Who this might be right for
Anthracycline Related Cardiotoxicity in Breast Cancer
Texas Tech University Health Sciences Center 70
Large-scale testing (Phase 3)UnknownNCT05792293
What this trial is testing

Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity

Who this might be right for
Doxorubicin Induced Cardiomyopathy
Ain Shams University 100
Testing effectiveness (Phase 2)WithdrawnNCT01097850
What this trial is testing

Topical Henna Preparation for the Treatment of Hand Foot Skin Syndrome

Who this might be right for
Hand Foot Skin Syndrome
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00377559
What this trial is testing

Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
Catharina Ziekenhuis Eindhoven 70
Testing effectiveness (Phase 2)Study completedNCT01205503
What this trial is testing

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Who this might be right for
Breast CancerNon-Hodgkin's Lymphoma
Mara Chambers 32
Not applicableUnknownNCT05733026
What this trial is testing

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients

Who this might be right for
Breast Cancer
Ain Shams University 200
Not applicableUnknownNCT05146843
What this trial is testing

The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients

Who this might be right for
Breast Neoplasms
D'Or Institute for Research and Education 44
Early research (Phase 1)Study completedNCT04023110
What this trial is testing

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Who this might be right for
CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more
Abramson Cancer Center at Penn Medicine 68
Not applicableNot Yet RecruitingNCT06500715
What this trial is testing

Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma

Who this might be right for
Febrile NeutropeniaSarcomaDoxorubicin Adverse Reaction+1 more
Shaare Zedek Medical Center 60
Not applicableStudy completedNCT03505164
What this trial is testing

The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor

Who this might be right for
Doxorubicin Adverse ReactionCardiomyopathies, SecondaryBreast Cancer
Rush University Medical Center 42
Not applicableUnknownNCT01246856
What this trial is testing

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study

Who this might be right for
Breast Cancer
Radboud University Medical Center 150
Testing effectiveness (Phase 2)UnknownNCT06092606
What this trial is testing

Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

Who this might be right for
CancerHeart FailureArrhythmia+2 more
Monyan Pharmaceutical (Shanghai) Co., Ltd. 90
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Not applicableUnknownNCT04461223
What this trial is testing

Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR

Who this might be right for
CardiotoxicityOsteosarcomaMyocardial Injury+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 55
Not applicableActive Not RecruitingNCT05078190
What this trial is testing

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer

Who this might be right for
Breast CancerCardiotoxicityDrug-Related Side Effects and Adverse Reactions+1 more
Abramson Cancer Center at Penn Medicine 200
Load More Results